8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-20-003875
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading a8-kchangeinofficers.htm…